Customer Background
A regional pathology group supporting multiple hospital and ambulatory sites needed a single view of Merit-based Incentive Payment System (MIPS) performance. Historically, Quality, Improvement Activities, Promoting Interoperability, and Cost results were tracked in separate spreadsheets, registry portals, and billing reports, making it difficult for leadership to understand incentive readiness or compare Traditional MIPS with emerging pathology-specific MVP options.
Objective
The objective was to build an executive dashboard that consolidates pathology MIPS performance at the practice level, supports a full switch between Traditional MIPS and the Pathology MVP, and clearly shows how readiness in each performance category contributes to the projected MIPS Final Score. The solution needed to be transparent, auditable, and aligned with College of American Pathologists guidance while preserving strict de-identification of patient data.
Approach
- Data Integration and Normalization - Combined EHR, LIS, billing, and registry extracts into a curated analytics model keyed to MIPS numerators and denominators, low volume thresholds, and CAP pathology measure specifications.
- Measure Mapping - Mapped pathology quality measures, Improvement Activities, Promoting Interoperability measures, and CMS cost indices to a consistent semantic layer, supporting both Traditional MIPS and the Pathology MVP scoring model.
- AI-enabled Analytics - Implemented an AI agent that scans de-identified data for measure logic anomalies, missing synoptic fields, and scoring edge cases, providing coaching insights directly in the dashboard.
- Executive Dashboards - Delivered the executive view with KPI cards, visualizations, and an AI insights panel, all designed to help clinical and operational leaders understand where to invest effort before the submission deadline.
Outcomes
- Consistent, practice-level view of pathology performance across Quality, IA, PI, and Cost in a single dashboard.
- Improved clarity on the tradeoffs between remaining on Traditional MIPS versus moving to the Pathology MVP.
- Reduction in manual MIPS reconciliation work through AI-assisted data validation and measure coaching.
- Increased confidence that projected MIPS Final Scores accurately reflect underlying pathology quality and operational performance.
MIPS Pathology Requirements Tracking | Executive Dashboard
Reporting Context: PY 2025 | Mode: Traditional MIPS
Projected MIPS Final Score
86.4
+5.2 vs prior year
Performance threshold: 82 points
Quality Performance
44.0 / 55
6 measures
Weighted decile based scoring across pathology quality measures
Improvement Activities
13.5 / 15
4 activities
Focus on care coordination, patient safety, and engagement
Promoting Interoperability
22.0 / 25
Active
HIE participation, public health reporting, and registry connections
Cost Performance
6.9 / 30
1 cost measure(s)
Indexes relative to CMS national benchmarks
Eligible Clinicians Meeting Low Volume Threshold
8 / 9
On track for full group participation
Based on PFS allowed charges and Medicare Part B volume
Annual Pathology Case Volume
18,420
37% complex cancer
Workload mix used to normalize quality and cost expectations
AI Data Quality Risk Index
Moderate
11 open, 63 resolved in 30 days
AI agent monitors numerator and denominator anomalies, missing fields, and measure logic drift
AI Insights and Measure Coaching
An embedded AI agent continuously reviews de-identified, aggregated MIPS data for this pathology practice. It monitors numerator and denominator trends, compares measure performance to CMS benchmarks, and inspects structured fields such as synoptic cancer checklists, SNOMED coding, and critical value flags.
- For Quality, the agent explains which pathology measures are driving the decile gains and highlights specimen types with rising turnaround variance.
- For IA, it verifies documentation evidence for each Improvement Activity and surfaces gaps that would prevent CMS credit if audited.
- For PI, it reconciles interface message volumes and registry acknowledgments with measure denominators to validate full PI scoring.
- For Cost, it compares the pathology case mix and site of service trends against applicable cost measures to explain cost index movements.
Current Coaching Focus
- Tighten documentation for cross coverage of critical results to secure higher Quality deciles.
- Increase electronic case exchange with tumor registries to sustain PI points under evolving CMS rules.
- Model impact of additional Improvement Activities on the projected MIPS Final Score before the submission deadline.